THERALYTICS Inc

Developed novel therapeutic agent targeting HPV lesions

Facebook Twitter LinkedIn

Startup biotech company (Nov 2025) with novel theralytic agents. Supportive preclinical studies completed, working toward IND designation for clinical evaluation.

Fundraise Details

This section is only visible to registered investors. Log in or register as an accredited investor to view.

Ready to Ask For Funding for your company?

Post a Funding Request